Calysta protein in salmon feed trials
CALYSTA, the company behind an alternative form of fish feed protein, is to partner with Norwegian research institution Nofima in largescale salmon trials, beginning in early 2019.
The company, which has backing from the feed giant Cargill, claims that its FeedKind protein, produced by natural fermentation, can improve growth rates, feed efficiency and fish health.
It provides the industry with the first scalable alternative protein requiring no wild caught fish or agricultural land.
Mari Moren, director of research at Nofima, said: ‘We are eager to do research on FeedKind as we believe that this may be an example of new protein sources that can contribute to a more sustainable aquaculture.‘
FeedKind has been approved for sale in the EU and several Asian countries. It has been shown to use 77-98 per cent less water and more than 98 per cent less land than alternative ingredients, such as soy or wheat proteins.